Today, for World Stroke Awareness Day, join the Sign Against Stroke in Atrial Fibrillation campaign to add your voice to this call for urgent action to avoid thousands of preventable afib-related strokes. Sign the Global AF Patient Charter on this page, and learn more about the Sign Against Stroke in Atrial Fibrillation campaign at: http://www.stopafib.org/newsitem.cfm/NEWSID/480/atrial-fibrillation-related-strokes/Sign-Against-%20Stroke
Read More
Here is an update on the DECAAF study that Dr. Nassir Marrouche presented at the European Society of Cardiology in Amsterdam today. According to Dr. Marrouche, the amount of fibrosis (scar tissue created in the heart by atrial fibrillation), as measured on pre-ablation MRIs (magnetic resonance imaging), predicts the success of catheter ablations for atrial …
Read More
As reported at the European Society of Cardiology in Amsterdam, among patients with 0-2 stroke risk factors, those with atrial fibrillation had a three-fold risk of stroke over those who didn’t have afib. But that difference declined as the number of risk factors increased. The risk of stroke was high in those with 3 or …
Read More
We’re finally getting a glimpse into what to expect from edoxaban, the 4th new anticoagulant medication. At the European Society of Cardiology in Amsterdam, it was reported that edoxaban was safer--in other words, had less bleeding--than warfarin for those with deep vein thrombosis (blood clots in the legs) or pulmonary embolism (blood clots in the …
Read More
This confirms what we already knew... As reported today at the European Society of Cardiology in Amsterdam: "Women with AF receive less anticoagulation treatment than men despite the fact that they are at greater risk of stroke. The new CHA2DS2-VASc score should be used more stringently, especially in women, to optimise their treatment. Treatment of …
Read More
People with atrial fibrillation may develop age-related cognitive decline (thinking and memory problems) at a younger age than those without afib, a new study says. We already knew that cognitive decline becomes more common as people get older, and that afib may have contributed to this cognitive decline. But we didn't know for sure until …
Read More
On Today’s Inspiring Women, host Deanne DeMarco interviewed Loretta Rosenmayer, CEO of Trench-It, and Mellanie True Hills, Founder and CEO of StopAfib.org. Mellanie’s interview starts at about 31 minutes into the program; however, if you happen to be a young woman in business, you’ll also enjoy listening to the interview with Loretta Rosenmayer, a very …
Read More
In this video interview, Dr. Andy Kiser discusses the hybrid ablation (also called the hybrid procedure) for atrial fibrillation to tailor treatment for individual patients. This hybrid approach combines a surgical ablation procedure and a catheter ablation in the same setting, and is done by a team that consists of both a surgeon and an …
Read More
In the late breaking clinical trials session at Heart Rhythm 2013, Dr. Nassir Marrouche presented results of the multicenter DECAAF trial. Dr. Marrouche talked with us on video about the results presented at HRS, including the role of hypertension (high blood pressure) in the development of atrial fibrosis and the evaluation by MRI of atrial …
Read More
In the late breaking clinical trials session at Heart Rhythm 2013, Dr. Sanjiv Narayan presented early results of the multicenter PRECISE-PAF trial of FIRM ablation without pulmonary vein isolation. We caught up with Dr. Narayan and he talked with us on video about these findings along with other FIRM results presented at HRS. To watch …
Read More